Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1994 Dec 17;309(6969):1631–1635. doi: 10.1136/bmj.309.6969.1631

Cardiology--II: Treatment of heart failure and atrial fibrillation and arrhythmias.

J McMurray 1, A Rankin 1
PMCID: PMC2542004  PMID: 7819948

Full text

PDF
1632

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler S. W., Remole S., Benditt D. G. Impact of implantable cardioverter-defibrillators on prognosis of cardiac arrest survivors. A continuing controversy. Circulation. 1993 Sep;88(3):1348–1350. doi: 10.1161/01.cir.88.3.1348. [DOI] [PubMed] [Google Scholar]
  2. Akhtar M., Jazayeri M. R., Sra J., Blanck Z., Deshpande S., Dhala A. Atrioventricular nodal reentry. Clinical, electrophysiological, and therapeutic considerations. Circulation. 1993 Jul;88(1):282–295. doi: 10.1161/01.cir.88.1.282. [DOI] [PubMed] [Google Scholar]
  3. Bardy G. H., Johnson G., Poole J. E., Dolack G. L., Kudenchuk P. J., Kelso D., Mitchell R., Mehra R., Hofer B. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation. 1993 Aug;88(2):543–547. doi: 10.1161/01.cir.88.2.543. [DOI] [PubMed] [Google Scholar]
  4. Calkins H., Leon A. R., Deam A. G., Kalbfleisch S. J., Langberg J. J., Morady F. Catheter ablation of atrial flutter using radiofrequency energy. Am J Cardiol. 1994 Feb 15;73(5):353–356. doi: 10.1016/0002-9149(94)90007-8. [DOI] [PubMed] [Google Scholar]
  5. Chen S. A., Chiang C. E., Yang C. J., Cheng C. C., Wu T. J., Wang S. P., Chiang B. N., Chang M. S. Radiofrequency catheter ablation of sustained intra-atrial reentrant tachycardia in adult patients. Identification of electrophysiological characteristics and endocardial mapping techniques. Circulation. 1993 Aug;88(2):578–587. doi: 10.1161/01.cir.88.2.578. [DOI] [PubMed] [Google Scholar]
  6. Choue C. W., Kim S. G., Fisher J. D., Roth J. A., Ferrick K. J., Brodman R., Frame R., Gross J., Furman S. Comparison of defibrillator therapy and other therapeutic modalities for sustained ventricular tachycardia or ventricular fibrillation associated with coronary artery disease. Am J Cardiol. 1994 Jun 1;73(15):1075–1079. doi: 10.1016/0002-9149(94)90286-0. [DOI] [PubMed] [Google Scholar]
  7. Coggins D. L., Lee R. J., Sweeney J., Chein W. W., Van Hare G., Epstein L., Gonzalez R., Griffin J. C., Lesh M. D., Scheinman M. M. Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. J Am Coll Cardiol. 1994 May;23(6):1333–1341. doi: 10.1016/0735-1097(94)90375-1. [DOI] [PubMed] [Google Scholar]
  8. Connolly S. J., Laupacis A., Gent M., Roberts R. S., Cairns J. A., Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991 Aug;18(2):349–355. doi: 10.1016/0735-1097(91)90585-w. [DOI] [PubMed] [Google Scholar]
  9. Domanski M. J., Saksena S. Evaluation of treatment strategies of malignant ventricular tachyarrhythmias in the era of the implantable defibrillator. Am J Cardiol. 1993 Aug 15;72(5):455–457. doi: 10.1016/0002-9149(93)91140-d. [DOI] [PubMed] [Google Scholar]
  10. Doval H. C., Nul D. R., Grancelli H. O., Perrone S. V., Bortman G. R., Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA) Lancet. 1994 Aug 20;344(8921):493–498. doi: 10.1016/s0140-6736(94)91895-3. [DOI] [PubMed] [Google Scholar]
  11. Echt D. S., Liebson P. R., Mitchell L. B., Peters R. W., Obias-Manno D., Barker A. H., Arensberg D., Baker A., Friedman L., Greene H. L. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991 Mar 21;324(12):781–788. doi: 10.1056/NEJM199103213241201. [DOI] [PubMed] [Google Scholar]
  12. Epstein L. M., Chiesa N., Wong M. N., Lee R. J., Griffin J. C., Scheinman M. M., Lesh M. D. Radiofrequency catheter ablation in the treatment of supraventricular tachycardia in the elderly. J Am Coll Cardiol. 1994 May;23(6):1356–1362. doi: 10.1016/0735-1097(94)90377-8. [DOI] [PubMed] [Google Scholar]
  13. Ezekowitz M. D., Bridgers S. L., James K. E., Carliner N. H., Colling C. L., Gornick C. C., Krause-Steinrauf H., Kurtzke J. F., Nazarian S. M., Radford M. J. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med. 1992 Nov 12;327(20):1406–1412. doi: 10.1056/NEJM199211123272002. [DOI] [PubMed] [Google Scholar]
  14. Fitzpatrick A. P., Lesh M. D., Epstein L. M., Lee R. J., Siu A., Merrick S., Griffin J. C., Scheinman M. M. Electrophysiological laboratory, electrophysiologist-implanted, nonthoracotomy-implantable cardioverter/defibrillators. Circulation. 1994 Jun;89(6):2503–2508. doi: 10.1161/01.cir.89.6.2503. [DOI] [PubMed] [Google Scholar]
  15. Garratt C. J. Who needs ventricular stimulation studies? Br Heart J. 1994 Apr;71(4):307–308. doi: 10.1136/hrt.71.4.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Haissaguerre M., Puel V., Bekheit S., Fisher B., Dartigues J. F., Egloff P., Le Metayer P., Clementy J., Warin J. F. Catheter ablation of accessory pathways in children. Eur Heart J. 1994 Feb;15(2):200–205. doi: 10.1093/oxfordjournals.eurheartj.a060476. [DOI] [PubMed] [Google Scholar]
  17. Haïssaguerre M., Gaïta F., Marcus F. I., Clémenty J. Radiofrequency catheter ablation of accessory pathways: a contemporary review. J Cardiovasc Electrophysiol. 1994 Jun;5(6):532–552. doi: 10.1111/j.1540-8167.1994.tb01293.x. [DOI] [PubMed] [Google Scholar]
  18. Hintringer F., Pürerfellner H., Aichinger J., Gmeiner R., Baumgartner G., Nesser H. J. Successful radiofrequency ablation of adenosine-sensitive right ventricular outflow tract tachycardia. Eur Heart J. 1994 Jun;15(6):858–861. doi: 10.1093/oxfordjournals.eurheartj.a060595. [DOI] [PubMed] [Google Scholar]
  19. Katritsis D., Bashir Y., Heald S., Poloniecki J., Ward D. E. Radiofrequency ablation of accessory pathways: implications of accumulated experience and time dedicated to procedures. Eur Heart J. 1994 Mar;15(3):339–344. doi: 10.1093/oxfordjournals.eurheartj.a060500. [DOI] [PubMed] [Google Scholar]
  20. Kim S. G., Maloney J. D., Pinski S. L., Choue C. W., Ferrick K. J., Roth J. A., Gross J., Brodman R., Furman S., Fisher J. D. Influence of left ventricular function on survival and mode of death after implantable defibrillator therapy (Cleveland Clinic Foundation and Montefiore Medical Center experience). Am J Cardiol. 1993 Dec 1;72(17):1263–1267. doi: 10.1016/0002-9149(93)90294-m. [DOI] [PubMed] [Google Scholar]
  21. Kim Y. H., Sosa-Suarez G., Trouton T. G., O'Nunain S. S., Osswald S., McGovern B. A., Ruskin J. N., Garan H. Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. Circulation. 1994 Mar;89(3):1094–1102. doi: 10.1161/01.cir.89.3.1094. [DOI] [PubMed] [Google Scholar]
  22. Kugler J. D., Danford D. A., Deal B. J., Gillette P. C., Perry J. C., Silka M. J., Van Hare G. F., Walsh E. P. Radiofrequency catheter ablation for tachyarrhythmias in children and adolescents. The Pediatric Electrophysiology Society. N Engl J Med. 1994 May 26;330(21):1481–1487. doi: 10.1056/NEJM199405263302103. [DOI] [PubMed] [Google Scholar]
  23. Lesh M. D., Van Hare G. F., Epstein L. M., Fitzpatrick A. P., Scheinman M. M., Lee R. J., Kwasman M. A., Grogin H. R., Griffin J. C. Radiofrequency catheter ablation of atrial arrhythmias. Results and mechanisms. Circulation. 1994 Mar;89(3):1074–1089. doi: 10.1161/01.cir.89.3.1074. [DOI] [PubMed] [Google Scholar]
  24. Manolis A. S. Transvenous endocardial cardioverter defibrillator systems. Is the future here? Arch Intern Med. 1994 Mar 28;154(6):617–622. [PubMed] [Google Scholar]
  25. Mason J. W. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. N Engl J Med. 1993 Aug 12;329(7):445–451. doi: 10.1056/NEJM199308123290701. [DOI] [PubMed] [Google Scholar]
  26. Mason J. W. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. N Engl J Med. 1993 Aug 12;329(7):452–458. doi: 10.1056/NEJM199308123290702. [DOI] [PubMed] [Google Scholar]
  27. McMurray J., Rankin A. Cardiology--I: Treatment of myocardial infarction, unstable angina, and angina pectoris. BMJ. 1994 Nov 19;309(6965):1343–1350. doi: 10.1136/bmj.309.6965.1343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Morady F., Harvey M., Kalbfleisch S. J., el-Atassi R., Calkins H., Langberg J. J. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation. 1993 Feb;87(2):363–372. doi: 10.1161/01.cir.87.2.363. [DOI] [PubMed] [Google Scholar]
  29. Nademanee K., Singh B. N., Stevenson W. G., Weiss J. N. Amiodarone and post-MI patients. Circulation. 1993 Aug;88(2):764–774. doi: 10.1161/01.cir.88.2.764. [DOI] [PubMed] [Google Scholar]
  30. Nakagawa H., Beckman K. J., McClelland J. H., Wang X., Arruda M., Santoro I., Hazlitt H. A., Abdalla I., Singh A., Gossinger H. Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation. 1993 Dec;88(6):2607–2617. doi: 10.1161/01.cir.88.6.2607. [DOI] [PubMed] [Google Scholar]
  31. Navarro-López F., Cosin J., Marrugat J., Guindo J., Bayes de Luna A. Comparison of the effects of amiodarone versus metoprolol on the frequency of ventricular arrhythmias and on mortality after acute myocardial infarction. SSSD Investigators. Spanish Study on Sudden Death. Am J Cardiol. 1993 Dec 1;72(17):1243–1248. doi: 10.1016/0002-9149(93)90291-j. [DOI] [PubMed] [Google Scholar]
  32. Newman D., Sauve M. J., Herre J., Langberg J. J., Lee M. A., Titus C., Franklin J., Scheinman M. M., Griffin J. C. Survival after implantation of the cardioverter defibrillator. Am J Cardiol. 1992 Apr 1;69(9):899–903. doi: 10.1016/0002-9149(92)90789-2. [DOI] [PubMed] [Google Scholar]
  33. Nicklas J. M., McKenna W. J., Stewart R. A., Mickelson J. K., Das S. K., Schork M. A., Krikler S. J., Quain L. A., Morady F., Pitt B. Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J. 1991 Oct;122(4 Pt 1):1016–1021. doi: 10.1016/0002-8703(91)90466-u. [DOI] [PubMed] [Google Scholar]
  34. O'Nunain S., Ruskin J. Cardiac arrest. Lancet. 1993 Jun 26;341(8861):1641–1647. doi: 10.1016/0140-6736(93)90770-h. [DOI] [PubMed] [Google Scholar]
  35. Petersen P., Boysen G., Godtfredsen J., Andersen E. D., Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989 Jan 28;1(8631):175–179. doi: 10.1016/s0140-6736(89)91200-2. [DOI] [PubMed] [Google Scholar]
  36. Powell A. C., Fuchs T., Finkelstein D. M., Garan H., Cannom D. S., McGovern B. A., Kelly E., Vlahakes G. J., Torchiana D. F., Ruskin J. N. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation. 1993 Sep;88(3):1083–1092. doi: 10.1161/01.cir.88.3.1083. [DOI] [PubMed] [Google Scholar]
  37. Schwartz P. J., Camm A. J., Frangin G., Janse M. J., Julian D. G., Simon P. Does amiodarone reduce sudden death and cardiac mortality after myocardial infarction? The European Myocardial Infarct Amiodarone Trial (EMIAT). Eur Heart J. 1994 May;15(5):620–624. doi: 10.1093/oxfordjournals.eurheartj.a060557. [DOI] [PubMed] [Google Scholar]
  38. Singer D. E., Hughes R. A., Gress D. R., Sheehan M. A., Oertel L. B., Maraventano S. W., Blewett D. R., Rosner B., Kistler J. P. The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study. Am Heart J. 1992 Dec;124(6):1567–1573. doi: 10.1016/0002-8703(92)90074-6. [DOI] [PubMed] [Google Scholar]
  39. Teo K. K., Yusuf S., Furberg C. D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA. 1993 Oct 6;270(13):1589–1595. [PubMed] [Google Scholar]
  40. Uretsky B. F., Young J. B., Shahidi F. E., Yellen L. G., Harrison M. C., Jolly M. K. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol. 1993 Oct;22(4):955–962. doi: 10.1016/0735-1097(93)90403-n. [DOI] [PubMed] [Google Scholar]
  41. Waagstein F., Bristow M. R., Swedberg K., Camerini F., Fowler M. B., Silver M. A., Gilbert E. M., Johnson M. R., Goss F. G., Hjalmarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 1993 Dec 11;342(8885):1441–1446. doi: 10.1016/0140-6736(93)92930-r. [DOI] [PubMed] [Google Scholar]
  42. Ward D. E., Camm A. J. Dangerous ventricular arrhythmias--can we predict drug efficacy? N Engl J Med. 1993 Aug 12;329(7):498–499. doi: 10.1056/NEJM199308123290710. [DOI] [PubMed] [Google Scholar]
  43. Wen M. S., Yeh S. J., Wang C. C., Lin F. C., Chen I. C., Wu D. Radiofrequency ablation therapy in idiopathic left ventricular tachycardia with no obvious structural heart disease. Circulation. 1994 Apr;89(4):1690–1696. doi: 10.1161/01.cir.89.4.1690. [DOI] [PubMed] [Google Scholar]
  44. Zarembski D. G., Nolan P. E., Jr, Slack M. K., Caruso A. C. Empiric long-term amiodarone prophylaxis following myocardial infarction. A meta-analysis. Arch Intern Med. 1993 Dec 13;153(23):2661–2667. [PubMed] [Google Scholar]
  45. Zipes D. P. Implantable cardioverter-defibrillator. Lifesaver or a device looking for a disease? Circulation. 1994 Jun;89(6):2934–2936. doi: 10.1161/01.cir.89.6.2934. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES